Pushkal Garg - Mar 3, 2025 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Signature
By: Brett Budzinski, Attorney-in-Fact For: Pushkal Garg
Stock symbol
ALNY
Transactions as of
Mar 3, 2025
Transactions value $
-$621,150
Form type
4
Date filed
3/5/2025, 04:21 PM
Previous filing
Mar 3, 2025
Next filing
Mar 25, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Award $0 +14.1K +109.06% $0.00 27.1K Mar 3, 2025 Direct F1, F2
transaction ALNY Common Stock Sale -$51.6K -213 -0.79% $242.37 26.9K Mar 3, 2025 Direct F3, F4
transaction ALNY Common Stock Sale -$57.2K -235 -0.87% $243.36 26.7K Mar 3, 2025 Direct F3, F5
transaction ALNY Common Stock Sale -$38.6K -158 -0.59% $244.41 26.5K Mar 3, 2025 Direct F3, F6
transaction ALNY Common Stock Sale -$28.5K -116 -0.44% $245.26 26.4K Mar 3, 2025 Direct F3, F7
transaction ALNY Common Stock Sale -$11.8K -48 -0.18% $246.18 26.3K Mar 3, 2025 Direct F3, F8
transaction ALNY Common Stock Sale -$1.24K -5 -0.02% $247.35 26.3K Mar 3, 2025 Direct F3, F9
transaction ALNY Common Stock Sale -$248 -1 0% $248.36 26.3K Mar 3, 2025 Direct F3
transaction ALNY Common Stock Sale -$142K -583 -2.21% $243.13 25.7K Mar 3, 2025 Direct F10, F11
transaction ALNY Common Stock Sale -$66.7K -273 -1.06% $244.43 25.5K Mar 3, 2025 Direct F10, F12
transaction ALNY Common Stock Sale -$28.7K -117 -0.46% $245.53 25.4K Mar 3, 2025 Direct F10, F13
transaction ALNY Common Stock Sale -$35.2K -147 -0.58% $239.25 25.2K Mar 4, 2025 Direct F10, F14
transaction ALNY Common Stock Sale -$82.6K -343 -1.36% $240.92 24.9K Mar 4, 2025 Direct F10, F15
transaction ALNY Common Stock Sale -$47.8K -198 -0.8% $241.60 24.7K Mar 4, 2025 Direct F10, F16
transaction ALNY Common Stock Sale -$29.1K -120 -0.49% $242.70 24.5K Mar 4, 2025 Direct F10, F17
holding ALNY Common Stock 431 Mar 3, 2025 by Managed Account F18
holding ALNY Common Stock 250 Mar 3, 2025 by Trust F19

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Award $0 +7.82K $0.00 7.82K Mar 3, 2025 Common Stock 7.82K $243.53 Direct F20
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.
F2 The Reporting Person has reported certain prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 14,137 newly awarded RSUs and 10,405 shares of common stock. The Reporting Person also holds 1,908 unvested RSUs that were previously reported in Table II.
F3 Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.87 to $242.86. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.89 to $243.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $243.90 to $244.90. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $244.91 to $245.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F8 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $246.00 to $246.71. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F9 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $247.04 to $247.52. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F10 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2024.
F11 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.62 to $243.58. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F12 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $244.04 to $244.80. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F13 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $245.07 to $245.74. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F14 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $238.93 to $239.40. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F15 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $240.18 to $241.17. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F16 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $241.21 to $242.02. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F17 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $242.46 to $242.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F18 Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
F19 Represents shares held in trust, of which the Reporting Persons spouse is co-trustee. The Reporting Person disclaims beneficial ownership of these shares, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F20 The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.